Perspective from Aysa Varshavsky, MD, PhD The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory multiple myeloma, according to phase ...
as a first-line treatment option for adult patients with newly diagnosed multiple myeloma who are not eligible for autologous stem cell transplant. In August, Sanofi released new results from the ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The treatment landscape for multiple myeloma is evolving rapidly, with novel therapies offering renewed hope for ...
From velvety purples to fiery reds, many people can see a spectrum of vivid colors via the human eye. Others, however, may have limited hue perception due to certain conditions. Animals ...